Molecular Formula | C7H17Cl2N2O3P |
Molar Mass | 279.1 |
Melting Point | 49-51 °C (lit.) |
Boling Point | 407.5°C at 760 mmHg |
Flash Point | >230°F |
Water Solubility | 40 g/L |
Solubility | H2O: 0.1g/mL, clear, colorless |
Vapor Presure | 5.72E-08mmHg at 25°C |
Appearance | Crystals or Crystalline Powder |
Color | White to almost white |
Merck | 14,2747 |
BRN | 8167897 |
Storage Condition | 2-8°C |
Physical and Chemical Properties | Water-soluble
40 g/L
49-53 ℃ |
In vitro study | Cyclophosphamide (CY) is a chemotherapeutic agent that has a dose-dependent dual effect on the immune system. Cyclophosphamide treatment enhances apoptosis and reduces homeostatic proliferation of regulated T cells. Cyclophosphamide down-regulates the expression of GITR and FoxP3, which is involved in the inhibitory activity of T(REGs). Cyclophosphamide increases the levels of CYP3A4,CYP2C8, and CYP2C9 proteins in primary human hepatocyte cultures, thereby increasing the rate of their own 4-hydroxylation in cultured hepatocytes. In the presence of metabolic activation, Cyclophosphamide mutates the base-pair substituted strain of Salmonella tryphimurium, but it appears negative in the E. coli chromogenic test. In the presence of metabolic activation, Cyclophosphamide is able to produce genetic mutations, chromosomal aberrations, micronuclei and sister chromatid interchanges in a variety of cultured cells, and in the absence of metabolic activation, A sister chromatid interchange occurs. |
In vivo study | Cyclophosphamide produces chromosomal lesions and micronuclei in rats, mice, and Chinese hamsters, as well as genetic mutations in mouse spot tests and Muta mouse transgenic lacZ constructs. Cyclophosphamide, added in a defined sequence to the GM-CSF-secreted, neu-expressing whole-cell vaccine, was able to enhance the vaccine's potential to retard tumor growth in neu-transgenic mice. Cyclophosphamide exerts its effect by enhancing the efficacy of the vaccine, rather than by direct cytolytic effects on cancer cells. |
Hazard Symbols | T - Toxic |
Risk Codes | R45 - May cause cancer R25 - Toxic if swallowed R61 - May cause harm to the unborn child R46 - May cause heritable genetic damage R36/37/38 - Irritating to eyes, respiratory system and skin. R23/24/25 - Toxic by inhalation, in contact with skin and if swallowed. |
Safety Description | S53 - Avoid exposure - obtain special instructions before use. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) S37/39 - Wear suitable gloves and eye/face protection S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
UN IDs | UN 3464 6.1/PG 3 |
WGK Germany | 3 |
RTECS | RP6157750 |
FLUKA BRAND F CODES | 10 |
HS Code | 29349990 |
Hazard Class | 6.1 |
Packing Group | II |
(IARC) carcinogen classification | 1 (Vol. 26, Sup 7, 100A) 2012 |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | cyclophoride Monohydrate is a nitrogen mustard alkylating agent that links an alkyl group to a guanine base of DNA. Cross-linking with DNA, resulting in DNA strand breaks, causing mutations. Has a cytotoxic effect. |
Use | antineoplastic agent. For malignant lymphoma effect is good, also has a certain effect on acute lymphoblastic leukemia, other chronic lymphocytic leukemia, breast cancer, ovarian cancer, testicular cancer, multiple myeloma, neuroblastoma, head and neck cancer and colon cancer are also effective. This product also has immunosuppressive effect. For the condensation of kidney disease and rheumatoid arthritis. The toxicity of the product, oral LD50 for mice 35094mg/kg. immunosuppressive and antineoplastic drugs. A cytotoxic nitrogen mustard derivative widely used in cancer chemotherapy |
production method | is obtained by chlorination, condensation and cyclization of diethanolamine. |